DESCRIBE <http://purl.uniprot.org/SHA-384/21C08A3168F78C1C0344F64210152C45C0E3A492C587B2D3C943C55CF226AEDCB6AB725E9502E2D88D4DDE1C7AEF640F>

Subject	Predicate	Object
http://purl.uniprot.org/SHA-384/21C08A3168F78C1C0344F64210152C45C0E3A492C587B2D3C943C55CF226AEDCB6AB725E9502E2D88D4DDE1C7AEF640F	http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/21C08A3168F78C1C0344F64210152C45C0E3A492C587B2D3C943C55CF226AEDCB6AB725E9502E2D88D4DDE1C7AEF640F	http://www.w3.org/2000/01/rdf-schema#comment	"miR-526b was decreased in CC cells and CC clinical specimens especially in CC specimens with stromal invasion pelvic lymph node metastasis and deficiency vaginal involvement. Moreover it was proved that the character of miR-526b in CC was dependent on controlling the PBX3-mediated EMT process."xsd:string
http://purl.uniprot.org/uniprot/#_F5B039E52C98756EF4109FBBD5B2AF8D0E400502BFF3167E9C21DA625D458727776E0BC4051D2773D965B66233943861	http://www.w3.org/1999/02/22-rdf-syntax-ns#subject	http://purl.uniprot.org/SHA-384/21C08A3168F78C1C0344F64210152C45C0E3A492C587B2D3C943C55CF226AEDCB6AB725E9502E2D88D4DDE1C7AEF640F
http://purl.uniprot.org/uniprot/P40426	http://purl.uniprot.org/core/mappedAnnotation	http://purl.uniprot.org/SHA-384/21C08A3168F78C1C0344F64210152C45C0E3A492C587B2D3C943C55CF226AEDCB6AB725E9502E2D88D4DDE1C7AEF640F
http://purl.uniprot.org/uniprot/#_P40426-mappedCitation-30859853	http://purl.uniprot.org/core/mappedAnnotation	http://purl.uniprot.org/SHA-384/21C08A3168F78C1C0344F64210152C45C0E3A492C587B2D3C943C55CF226AEDCB6AB725E9502E2D88D4DDE1C7AEF640F